Articles published by Business Wire

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Rimini Street Announces Participation in the ROTH Capital Partners 38th Annual Investor Conference

March 17, 2026

From Rimini Street, Inc.

Via Business Wire

The Cannabist Company Further Extends Forbearance Agreement With Senior Noteholders

March 17, 2026

From The Cannabist Company Holdings Inc.

Via Business Wire

Research Quest Celebrates 10-Year Anniversary and 1 Million Learning Sessions

March 17, 2026

From The Natural History Museum of Utah

Via Business Wire

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

March 17, 2026

From Stoke Therapeutics, Inc.

Via Business Wire

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

March 17, 2026

From Kroll Bond Rating Agency, LLC

Via Business Wire

PIMCO Canada Corp. Announces Monthly Distributions for PIMCO Canada Exchange Traded Series

March 17, 2026

From PIMCO Canada Corp.

Via Business Wire

Aptar Announces Gael Touya as its Next Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year

March 17, 2026

From AptarGroup, Inc.

Via Business Wire

Granite REIT Declares Distribution for March 2026

March 17, 2026

From Granite Real Estate Investment Trust

Via Business Wire

Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026

March 17, 2026

From Aarvik Therapeutics

Via Business Wire

JPMorganChase Declares Common Stock Dividend

March 17, 2026

From JPMorgan Chase & Co.

Via Business Wire

First Farmers and Merchants Corporation Declares Quarterly Cash Dividend of $0.29 Per Share

March 17, 2026

From First Farmers and Merchants Corporation

Via Business Wire

Verastem Oncology Announces Abstracts Accepted for Presentation on AVMAPKI™ FAKZYNJA™ (avutometinib capsules; defactinib tablets) Combination Therapy at the Society of Gynecologic Oncology 2026 Annual Meeting on Women’s Cancers

March 17, 2026

From Verastem Oncology

Via Business Wire

JPMorganChase to Host First-Quarter 2026 Earnings Call

March 17, 2026

From JPMorgan Chase & Co.

Via Business Wire

Fifth Third Bancorp Announces Cash Dividends

March 17, 2026

From Fifth Third Bancorp

Via Business Wire

Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer

March 17, 2026

From Agenus Bio

Via Business Wire

Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)

March 17, 2026

From Zai Lab Limited

Via Business Wire

Synthekine Announces AACR 2026 Oral Presentation of Updated Phase 1a/1b Clinical and Translational Data for STK‑012 in First‑Line Nonsquamous NSCLC with Features of Immunotherapy Resistance

March 17, 2026

From Synthekine Inc.

Via Business Wire

UnitedHealth Group Announces Earnings Release Date

March 17, 2026

From UnitedHealth Group

Via Business Wire

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

March 17, 2026

From Fulgent Genetics, Inc.

Via Business Wire

Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026

March 17, 2026

From Exact Sciences Corp.

Via Business Wire

Oklo’s Atomic Alchemy Announces U.S. Department of Energy Approval for Nuclear Safety Design Agreement of its Groves Isotopes Test Reactor

March 17, 2026

From Oklo Inc.

Via Business Wire

Beazer Homes Announces Expansion of Revolving Credit Facility to $525 million

March 17, 2026

From Beazer Homes USA, Inc.

Via Business Wire

Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026

March 17, 2026

From Frontier Medicines Corporation

Via Business Wire

NVIDIA Nemotron Powers Ceramic Supervised Generation to Ground AI Responses at Enterprise Scale

March 17, 2026

From Ceramic

Via Business Wire

Pheast Therapeutics to Present Initial Phase 1a Clinical Data and Two New Preclinical Studies of PHST001, a Novel Anti-CD24 Antibody, at AACR 2026

March 17, 2026

From Pheast Therapeutics

Via Business Wire

Akamis Bio to Present Initial Data from the Phase 1b FORTRESS Study of NG-350A in Mismatch Repair-Proficient Locally Advanced Rectal Cancer at AACR 2026

March 17, 2026

From Akamis Bio

Via Business Wire

SingleCell Biotechnology to Present High-Throughput Single-Cell Phenotyping Platform at AACR Annual Meeting

March 17, 2026

From SingleCell Biotechnology

Via Business Wire

Soley Therapeutics to Unveil a First-in-Class Small Molecule CKAP2 Modulator with Selective Anti-Tumor Activity at AACR 2026

March 17, 2026

From Soley Therapeutics

Via Business Wire

Onchilles Pharma to Present New Preclinical Data on Systemically Delivered NEU-002 Program at AACR 2026

March 17, 2026

From Onchilles Pharma

Via Business Wire

Orum Therapeutics to Present New Preclinical Data on ORM-1153, a CD123-Targeting Degrader Antibody Conjugate, at the AACR Annual Meeting 2026

March 17, 2026

From Orum Therapeutics

Via Business Wire

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.